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ABSTRACT
Purpose: In 2015, to determine where interventions are needed to eliminate trachoma as a public
health problem from Egypt, we initiated population-based prevalence surveys using the Global
Trachoma Mapping Project platform in four suspected-endemic marakez (districts; singular:
markaz) of the governorates of Elmenia and Bani Suef.
Methods: In each markaz, 30 households were selected in each of 25 villages. Certified graders
examined a total of 3682 children aged 1–9 years in 2993 households, noting the presence or
absence of trachomatous inflammation—follicular (TF) and trachomatous inflammation—intense
(TI) in each eye. A total of 5582 adults aged ≥15 years living in the same households were
examined for trachomatous trichiasis (TT). Household-level access to water and sanitation was
recorded.
Results: Three of four marakez had age-adjusted TF prevalence estimates in 1–9-year olds of
>10%; the other markaz had a TF prevalence estimate of 5–9.9%. Estimates of the age- and
gender-adjusted prevalence of unmanaged TT in adults ranged from 0.7% to 2.3%. Household-
level access to water and sanitation was high. (We did not, however, measure use of water or
sanitation facilities.)
Conclusions: Each of the four marakez surveyed has trachoma as a public health problem, with a
need for implementation of the SAFE (surgery, antibiotics, facial cleanliness, environmental
improvement) strategy. Further mapping is also required to determine the need for interventions
in other areas of Egypt.
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Background
With an estimated 89million residents,1 Egypt is the most
populous country in the Middle East. However, it fares
better than some of its neighbours on a variety of health
indicators (including deaths from malaria, maternal and
infant mortality rates, and prevalence of HIV); neglected
tropical diseases such as schistosomiasis, soil-transmitted
helminths, and trachoma are endemic.2,3
Trachoma’s presence in Egypt was documented in the
Ebers medical papyrus dating from 1500 BC.4 During
the Napoleonic wars in the early 1800s, troops deployed
to Egypt were heavily affected.5 At the beginning of the
twentieth century, in some areas, nearly all young chil-
dren developed active disease, and more than two-thirds
of adults were observed to have trichiasis;6,7 from 1903 to
1923, seminal work on trachoma was undertaken in
Egypt by Arthur Ferguson MacCallan.8 In the 1970s
and 1980s, it was still a widespread problem, including
in the capital, Cairo.9,10 In the mid-1980s, hyperendemic
trachoma was seen in two rural communities of Beheira
Governorate in the Nile Delta: active trachoma was pre-
sent in 59% of 3-year olds, while trichiasis and/or
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entropion were seen in children as young as 9 years old
and affected a staggering 75% of adult females.11,12
In 1999, a population-based survey in the Nile Delta
Governorate of Elmenofiya found that 37% of 2–6-year
olds had active trachoma, while 6.5% of adults had
trichiasis.13 A 2002 population-based survey of Elmenia
Governorate estimated the prevalence of active tra-
choma in 2–10-year olds to be 42%, and the prevalence
of trichiasis in ≥50-year olds to be 6.2%.14 In 2003,
trachoma rapid assessments (TRAs)15 were undertaken
in 15 villages of Elfayoum Governorate. The village-level
proportions of 2–10-year-old children observed to have
active trachoma ranged from 16% to 85%.16 A further
series of modified TRAs was undertaken in 2010–2011
in 78 villages of four governorates; the proportions of
villages in which ≥10% of children examined had the
active trachoma sign trachomatous inflammation—fol-
licular (TF)17 were 6/20 in Elfayoum, 18/20 in Elmenia,
19/20 in Elmenofiya, and 16/18 in Kafr Elsheikh.18
Transmission of trachoma’s causative agent,
Chlamydia trachomatis,19 is thought to be facilitated by
a combination of factors including poor sanitation,11,20
inadequate access to water for face-washing,21,22 and
overcrowding.23,24 Despite economic improvements
across Egypt and the introduction of sewerage to many
areas of the Nile Delta in recent decades, trachoma is
thought to remain a threat to public health in parts of
the country. We sought to collect contemporary data
necessary for planning interventions against this disease:
specifically, population-based prevalence estimates of
TF, trachomatous trichiasis (TT) and access to water
and sanitation.25,26
Methods
Ethical considerations
Ethics approval was received from the Research Ethics
Committee of the London School of Hygiene &
Tropical Medicine (reference numbers 6319 and 8355)
and the Egypt National Ministry of Health Ethics
Committee (20 May 2013). Verbal informed consent
was obtained from all adults examined and from the
household head on behalf of children in their care.
Study design
We used the principles and protocols of the Global
Trachoma Mapping Project (GTMP).27,28 The survey
sample size in each evaluation unit was based on an
expected TF prevalence of 10% and a desire to be 95%
confident of estimating the true TF prevalence with
absolute precision of 3%. The design effect was
estimated at 2.65, leading to our sample size estimate
of 1019 1–9-year-olds, which was then inflated by 20%
to account for partial non-response.27 We did not cal-
culate a specific sample size for TT, for which preva-
lences are generally very low, but instead used a
household-sampling approach in which a fixed number
of households were selected in each cluster, with that
number determined by the number of children that we
needed to include to generate an adequate sample size
for TF.27
We undertook population-based surveys in the
Governorates of Elmenia and Bani Suef, using the mar-
kaz (district; plural: marakez) as the evaluation unit.
Due to constraints in availability of personnel, only
four surveys could be conducted. Elmenia
Governorate was believed (on the basis of recent
research29) to have a high TT burden; its most north-
ern, most southern, and a central markaz were selected
for inclusion. Bani Suef Governorate lies just to the
north of Elmenia Governorate. Its most southern mar-
kaz was surveyed, based on the understanding that local
conditions here were most similar to those in Elmenia.
Within each markaz, clusters were selected by creating
a list of villages with corresponding village-level popu-
lation estimates, then systematically sampling from that
list with probability proportional to population size.26
In order to select sufficient households in which
1019 × 1.2 = 1222 one-to-nine-year olds would be
resident, 25 villages were selected in each markaz, and
30 households were chosen in each selected village. A
compact segment sampling technique was employed to
select households.30–35
Fieldwork
Trachoma grading was undertaken according to the
WHO simplified grading scheme,17 using 2.5× binocu-
lar loupes (OptiVISOR, Donegan Optical, Lenexa, KS,
USA) and sunlight illumination. Graders and data
recorders were trained prior to the surveys and certified
according to the standardized training protocols of the
GTMP, as described elsewhere.27 Version 3 of the
training system was used.36
All consenting residents in the household aged
≥1 year were examined for trichiasis, TF, and tracho-
matous inflammation—intense (TI). Eyes with trichia-
sis were considered to have TT if they also had TS, or if
the eyelid could not be everted for conjunctival exam-
ination by the grader. Participants identified to have
trichiasis were asked whether they had been offered
surgery or epilation by a health professional. All chil-
dren identified as having active trachoma (TF and/or
TI in one or both eyes) were provided with two tubes of
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1% tetracycline eye ointment and their parents or guar-
dian were instructed on how to use it. Participants with
trichiasis were referred for surgery.
Data recording and analysis
Data entry and upload was accomplished via the
bespoke Open Data Kit-based GTMP data capture sys-
tem running on Android smartphones.27 Data were
encrypted during transit and stored in a secure server
with only the study investigators having access; clean-
ing was undertaken by the GTMP data managers (AB
and RW). TF data were adjusted at cluster level for the
age of those examined, in 1-year age bands. TT data
were adjusted at cluster level for age and gender of
those examined, in 5-year age bands. Markaz-level esti-
mates were generated by taking the arithmetic mean of
the adjusted cluster-level proportions. Confidence
intervals for TF and TT prevalence estimates were
determined by bootstrapping the adjusted cluster-level
proportions of each sign, with replacement, over 10,000
replicates.
Results
Surveys were conducted from 29 November to 25
December 2015 in Abu Quorquas, Deir Mawass and
Matai marakez of Elmenia Governorate, and Elfashn
markaz of Bani Suef Governorate. Field teams visited a
total of 2993 households in 100 clusters across the four
marakez. In total, of 3708 1–9-year-old children
resident in selected households, 3682 were examined
(Table 1).
The estimated age-adjusted markaz-level TF preva-
lence in 1–9-year olds ranged from 8.4% to 25.3%
across the four marakez (Table 2, Figure 1). A total of
134 individuals aged ≥15 years had TT, of whom 46
had bilateral TT. The estimated age- and gender-
adjusted prevalence of TT exceeded 1% in each of the
four marakez (Table 2, Figure 2). In Elfashn, 14 (64%)
of the 22 individuals identified as having TT had been
offered surgery or epilation by the health system; cor-
responding proportions elsewhere were 8/26 (31%,
Matai), 17/59 (29%, Deir Mawass), and 7/27 (26%,
Abu Quorquas).
Based on these prevalence estimates for TF and TT,
applied to 2017 population estimates, for trachoma elim-
ination purposes, >1.7 million people in the four marakez
should receive antibiotics, facial cleanliness promotion,
and environmental improvement and 8712 people
require eyelid surgery to correct TT (Table 3).
Discussion
In the absence of an effective vaccine,37 the public
health approach to preventing trachoma blindness
involves reducing C. trachomatis transmission inten-
sity by maximising access to water and sanitation and
encouraging personal hygiene;38–40 periodically clear-
ing prevalent infection with antibiotics;41 and pre-
venting further trachoma-related vision loss in those
who already have trichiasis through provision of
quality eyelid surgery.42 These interventions together
Table 1. Adults and children resident, examined, absent and refused, by markaz, Global Trachoma Mapping Project, Egypt, 2015.
Markaz
Children aged 1–9 years Adults aged ≥15 years
Enumerated Examined Absent Refused Enumerated Examined Absent Refused
Abu Quorquas 925 916 (99.0) 6 (0.6) 3 (0.3) 1502 1479 (98.5) 16 (1.1) 6 (0.4)
Deir Mawass 1098 1097 (99.9) 1 (0.1) 0 (0.0) 1458 1400 (96.0) 54 (3.7) 4 (0.3)
Matai 842 837 (99.4) 4 (0.5) 1 (0.1) 1513 1480 (97.8) 14 (0.9) 19 (1.3)
Elfashn 843 832 (98.7) 11 (1.3) 0 (0.0) 1556 1223 (78.6) 299 (19.2) 33 (2.1)
Total 3708 3682 (99.3) 22 (0.6) 4 (0.1) 6029 5582 (92.6) 383 (6.4) 62 (1.0)
Table 2. Prevalence of trachomatous inflammation—follicular (TF) and trachomatous inflammation—intense (TI) in 1–9-year olds,
and prevalence of trachomatous trichiasis (TT) in ≥15-year olds, four marakez of Elmenia and Bani Suef Governorates, Global
Trachoma Mapping Project, Egypt, 2015.
Markaz
Age-adjusteda prevalence
of TF in 1–9-year olds
(95% CI)
Age-adjusteda prevalence
of TI in 1–9-year olds
(95% CI)
Age- and gender-adjustedb
prevalence of TT in ≥15-year olds
(95% CI)
Age- and gender-adjustedb prevalence
of unmanaged TT in ≥15-year olds
(95% CI)
Abu Quorquas 12.0 (7.5–18.2) 3.5 (1.8–5.5) 1.1 (0.5–1.9) 0.8 (0.4–1.5)
Deir Mawass 25.3 (19.2–32.6) 7.0 (3.8–10.7) 3.1 (1.9–4.6) 2.3 (1.2–3.6)
Matai 8.4 (5.6–10.7) 0.9 (0.2–1.6) 1.2 (0.5–1.9) 0.9 (0.4–1.4)
Elfashn 11.6 (7.3–17.3) 8.0 (4.6–11.8) 1.1 (0.5–1.9) 0.7 (0.2–1.5)
aAdjusted for age in 1-year age bands (see text).
bAdjusted for gender and age in 5-year age bands (see text).
CI: Confidence interval.
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comprise the “SAFE strategy”: surgery, antibiotics,
facial cleanliness, environmental improvement.43 The
SAFE strategy works44,45 and is recommended by the
World Health Organization, which leads an Alliance
aiming to eliminate trachoma as a public health pro-
blem by 2020. SAFE strategy interventions, however,
have to compete for prioritization in a crowded pub-
lic health landscape. Robust prevalence data are
required to make the case for funding. Though
there are some limitations of our work here—parti-
cularly the relatively large size of evaluation units
surveyed—we believe that our estimates are of evi-
dence-based metrics, are reproducible, and justify
planning for SAFE strategy implementation in the
areas surveyed.
In three of four suspected trachoma-endemic mara-
kez of Egypt, we found the TF prevalence to be ≥10%. In
Matai, the fourthmarkaz, TF prevalence was 8.5%. Based
on WHO guidelines,26 Abu Quorquas, Deir Mawass,
and Elfashn should be managed with three annual
rounds of antibiotic mass drug administration (MDA)
plus initiatives to ensure facial cleanliness and improve
the environment, before a repeat prevalence survey
6–12 months after the third MDA round. In Matai, one
round of MDA, facial cleanliness, and environmental
improvement activities are needed before re-survey. In
Figure 1. Prevalence of trachomatous inflammation—follicular (TF) in 1–9-year olds, four marakez of Elmenia and Bani Suef
Governorates, Global Trachoma Mapping Project, Egypt, 2015.
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each round, antibiotic coverage of at least 80% of the
markaz population is recommended.46,47 Although
WHO guidelines recommend that the A, F, and E
components of the SAFE strategy be implemented wher-
ever the TF prevalence exceeds the 5% elimination
threshold, it is notable that access to water and sanitation
Figure 2. Prevalence of trachomatous trichiasis (TT) in ≥15-year olds, four marakez of Elmenia and Bani Suef Governorates, Global
Trachoma Mapping Project, Egypt, 2015.
Table 3. Estimated numbers of people needing surgery (S) for trachomatous trichiasis (TT), antibiotics (A), facial cleanliness (F), and
environmental improvement (E) interventions, for trachoma elimination purposes, in four marakez of Elmenia and Bani Suef
Governorates, Egypt, 2017.
Markaz
Number of
people with TT
Number of people with
unmanaged TT
Number of people needing S to achieve the
TT elimination threshold
Number of people needing A, F, and E
(2017 population estimates)
Abu Quorquas 3590 2611 1958 593,356
Deir Mawass 6505 4826 4407 381,535
Matai 2000 1500 1166 302,978
Elfashn 2598 1653 1181 429,434
Total 14,693 10,590 8712 1707,303
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in these four marakez was nearly universal. In each
markaz, >95% of households had an improved water
source in the residence or yard, and all households
visited had access to an improved latrine (Table 4).
These levels of access exceed by some margin the access
thresholds expected to confer herd protection against
trachoma20,48—a demonstration of the heterogeneity of
environmental correlates of trachoma and the fact that
access to sanitation hardware does not necessarily lead to
protection from diseases associated with its absence49:
access may still be inadequate for some population sub-
sets, or facilities may not be used in ways that decrease
the risk of C. trachomatis transmission. Anecdotally at
least, in areas of Egypt in which mains sewerage is not
available, people often defaecate where their animals are
kept, rather than in household latrines.
The prevalence of unmanaged TT ranged from 0.7%
(Elfashn) to 2.3% (Deir Mawass) in the four marakez
surveyed here. Elimination of trachoma as a public
health problem requires that the prevalence of TT
unknown to the health system be reduced to <0.2% in
adults.50 Community-based case identification and pro-
vision of quality lid surgery by certified operators51 is
urgently needed in these populations to stem the tide of
trachoma-related blindness and visual impairment.
These findings indicate the urgent need to implement
the SAFE strategy for trachoma elimination in all four
marakez. F and E interventions should incorporate estab-
lished techniques for achieving sustained behaviour
change.52 Priority should be given to Deir Mawass,
where prevalences of both TF and TT were the highest
of the four marakez, and the proportion of people with
TT who had previously been offered management was
the lowest. In all, however, >1.7 million people in these
four marakez need services to eliminate trachoma as a
public health problem—and it is likely that other markaz
in Egypt will also need interventions, a hypothesis that
will need to be confirmed or refuted through further
population-based surveys.25,53 It is currently estimated
that at least 29 marakez still need to undergo baseline
surveys. Of Egypt’s international neighbours, only
Sudan23,54 is currently thought to have a public health
problem from trachoma, so cross-border issues are not
currently believed to be a priority here.
Global progress towards the target of eliminating
trachoma as a public health problem has recently gath-
ered pace, with a number of countries now validated by
the World Health Organization as having achieved that
milestone at national level.55 Armed with the evidence
generated by this series of surveys and those that will
follow, Egypt can now proceed to trachoma action
planning56 and engage with relevant stakeholders, start-
ing along the path to national trachoma elimination.
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